NAFLD (mild fibrosis) F0 to F2 ( n = 8) | NAFLD (severe fibrosis) F3 to F4 ( n = 9) | Statistical significance | |
---|---|---|---|
Hypertension (N, %) | 5 (62.5%) | 4 (44%) | ns |
Any hypertensive medication (N, %) | 5 (62.5%) | 6 (66%) | ns |
T2DM (N, %) | 8 (100%) | 8 (100%) | ns |
Insulin treated (N, %) | 3 (37.5%) | 3 (33.3%) | ns |
Oral medication treated (N, %) | 3 (37.5%) | 7 (77.7%) | ns |
Diet treated (N, %) | 2 (25%) | 1 (11.1%) | ns |
Cardiovascular disease (N, %) | 2 (25%) | 2 (22.2%) | ns |
Dyslipidemia treated with lipid lowering agents (N, %) | 4 (50%) | 6 (66.6%) | ns |
1 Med (N, %) | 3 (37.5%) | 6 (66.6%) | ns |
>2 Meds (N, %) | 1 (12.5%) | 0 (0%) | ns |